Investor profile
Curie Capital has backed 3 European tech companies across 3 funding rounds between 2022 and 2024, joining rounds totalling €163M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Citryll | Netherlands | 1 | €85M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Citryll | Series B | €85M | 2024-12 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| TargED Biopharmaceuticals | Series A | €39M | 2022-02 |
